MBX Biosciences, Inc.

Nasdaq:MBX

Pharmaceutical Preparations·CARMEL, IN

Financials

5 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	3/17/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→

Earnings Releases (8-K)

7 shown

Filed	Period
1/12/26	Q4 FY2026	→
11/6/25	Q3 FY2025	→
8/7/25	Q3 FY2025	→
5/12/25	Q2 FY2025	→
3/17/25	Q1 FY2025	→
1/7/25	Q4 FY2025	→
↓

News (8-K)

12 shown

Filed	Type	Description
3/9/26	Reg FD	Regulation FD Disclosure	→
2/27/26	Exec Change	Entry into a Material Definitive Agreement	→
2/5/26	Other	Other Events	→
1/22/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
9/26/25	Agreement	Entry into a Material Definitive Agreement	→
9/22/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

12 shown

Filed	Form	Description
11/6/25	S-3	S-3	→
9/25/25	424B4	424B4	→
9/24/25	S-1MEF	S-1MEF	→
9/22/25	S-1	S-1	→
4/23/25	ARS	ARS	→
3/17/25	S-8	S-8	→
↓

Filing History(165 filings)

TypeDateAccessionPeriodSize

8-K

Mar 9, 2026

0001193125-26-0976118-K

Mar 9, 2026

200.3 KB

Feb 27, 2026

0001193125-26-0825624

Feb 26, 2026

7.7 KB

8-K

Feb 27, 2026

0001193125-26-0792868-K

Feb 24, 2026

2.4 MB

SCHEDULE 13D/A

Feb 11, 2026

0000947871-26-000114

—

30.4 KB

SCHEDULE 13G/A

Feb 10, 2026

0000902219-26-000071

—

16.8 KB

8-K

Feb 5, 2026

0001193125-26-0394758-K

Feb 4, 2026

151.2 KB

Feb 3, 2026

0001193125-26-0355874

Feb 2, 2026

6.9 KB

Feb 3, 2026

0001193125-26-0355844

Feb 2, 2026

6.9 KB

Feb 3, 2026

0001193125-26-0355824

Feb 2, 2026

8.0 KB

Jan 22, 2026

0001193125-26-0187024

Jan 20, 2026

5.3 KB

Jan 22, 2026

0001193125-26-0187013

Jan 20, 2026

14.1 KB

8-K

Jan 22, 2026

0001193125-26-0187008-K

Jan 20, 2026

231.7 KB

SCHEDULE 13G

Jan 21, 2026

0002012383-26-000690

—

10.5 KB

144

Jan 12, 2026

0001959173-26-000259

—

5.3 KB

8-K

Jan 12, 2026

0001193125-26-0096428-K

Jan 11, 2026

256.8 KB

EFFECT

Dec 8, 2025

9999999995-25-003581

—

1.7 KB

Nov 25, 2025

0001193125-25-2946754

Nov 22, 2025

5.1 KB

SCHEDULE 13G/A

Nov 14, 2025

0001193125-25-282917

—

7.7 KB

SCHEDULE 13G/A

Nov 12, 2025

0001903360-25-000005

—

6.6 KB

SCHEDULE 13D/A

Nov 10, 2025

0001072613-25-000781

—

76.4 KB

Nov 7, 2025

0001193125-25-2711184

Nov 6, 2025

5.2 KB

S-3

Nov 6, 2025

0001193125-25-268202S-3

—

4.5 MB

10-Q

Nov 6, 2025

0001193125-25-26814810-Q

Sep 30, 2025

8.2 MB

8-K

Nov 6, 2025

0001193125-25-2681468-K

Oct 31, 2025

369.3 KB

Oct 28, 2025

0001193125-25-2524044

Oct 24, 2025

7.9 KB

25 filings shown

MBX Biosciences, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(165 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/27/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
2/3/26	4	4	→
1/22/26	4	4	→
1/22/26	3	3	→
↓

Filed	Form	Description
2/11/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
2/10/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/21/26	SCHEDULE 13G	SCHEDULE 13G	→
1/12/26	144	144	→
12/8/25	EFFECT	EFFECT	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓